title: Acute hepatitis B virus window-period blood donations detected by individual-donation nucleic acid testing: a report on the first two cases found and interdicted in Spain.
abstract: BACKGROUND
  Mathematical models predict that, in Spain, a significant number of blood units will be obtained during the window period of the hepatitis B virus (HBV) infection. Routine nucleic acid testing (NAT) on individual blood units may provide experimental data to evaluate such a theoretical risk.
  
  
  METHODS
  Between February and July 2005, a total of 34,631 individual units were screened for HBV DNA by a multiplex transcription-mediated amplification (TMA) test. Units that repeatedly reacted in the test, but did not react for HBV surface antigen (HBsAg), were submitted to additional testing by both molecular and conventional assays, and the donors were recalled for follow-up studies and the collection of clinical and epidemiologic data.
  
  
  RESULTS
  Confirmatory testing and follow-up studies identified 2 blood units donated during the HBV infection window period (1/17,316 units studied). Sequencing of amplification products obtained by nested polymerase chain reaction (n-PCR) revealed two HBV strains from genotypes D/ayw3 and F/adw4q-, but did not identify HBsAg mutants. The HBV DNA concentration in the index donations was estimated to be below the n-PCR detection level (180 IU/mL), in both cases. One donor developed acute hepatitis 2 months after donating blood, but the other remained asymptomatic and displayed normal alanine aminotransferase levels at follow-up.
  
  
  CONCLUSIONS
  The HBV infection window period is a real issue in the setting of Spanish blood transfusions. NAT of individual units by TMA would make a significant contribution to improving the safety of the blood supply in Spain. Additional studies involving a larger number of units and longer periods of time are required, however, to ascertain the true incidence of the problem in this country.
authors.affiliation: Spanish Red Cross Blood Transfusion Center, Madrid, Spain.
authors.forename: Rocio
authors.initials: R
authors.lastname: González
authors.forename: José Manuel
authors.initials: JM
authors.lastname: Echevarria
authors.forename: Ana
authors.initials: A
authors.lastname: Avellón
authors.forename: Luisa
authors.initials: L
authors.lastname: Barea
authors.forename: Emma
authors.initials: E
authors.lastname: Castro
mesh_terms: D000208:Acute Disease; D000328:Adult; D001782:Blood Donors / Q000600:supply & distribution*; D004279:DNA, Viral / Q000097:blood; D018562:Disease Transmission, Infectious / Q000517:prevention & control; D005260:Female; D005838:Genotype; D006509:Hepatitis B / Q000175:diagnosis* / Q000635:transmission; D006515:Hepatitis B virus / Q000235:genetics; D006801:Humans; D008297:Male; D021141:Nucleic Acid Amplification Techniques; D013030:Spain; D013997:Time Factors
chemical_list: D004279:DNA, Viral